Steve Xu
About Steve Xu
Steve Xu serves as the Chief Executive Officer of Sibel Health and holds the position of Ruth K. Freinkel MD Professor at Northwestern University's Feinberg School of Medicine. He is an inventor with multiple patents in digital health, has authored over 140 peer-reviewed publications, and has extensive experience in medical research and innovation.
Work at Sibel Health
Steve Xu serves as the Chief Executive Officer of Sibel Health, a position he has held since 2022. Under his leadership, the company has achieved multiple FDA 510(k) clearances for its advanced monitoring solutions. He has been instrumental in launching Sibel Health's technology in over 20 countries and has supported more than 30 major clinical trials. His role includes overseeing the development and implementation of innovative health monitoring technologies, which have monitored 15,000 individuals worldwide.
Education and Expertise
Steve Xu has an extensive educational background in medicine and engineering. He earned his Bachelor of Science in Engineering from Rice University, followed by a Master of Science in Health Policy and Finance from The London School of Economics and Political Science. He completed his medical degree at Harvard University. His expertise spans digital health, medical devices, and health policy, with a focus on neonatal intensive care unit monitoring and pregnancy monitoring innovations.
Background
Steve Xu has held various significant positions throughout his career. He was a medical student at Harvard Medical School from 2010 to 2014. He co-founded Sonica Health, where he worked from 2018 to 2022. Currently, he is also the Ruth K. Freinkel MD Professor at Northwestern University - The Feinberg School of Medicine, a role he has occupied since 2017. Additionally, he serves as the Head of the Medical Advisory Board at Geologie since 2019 and is a committee member at Advancing Innovation in Dermatology, Inc. since 2016.
Achievements
Steve Xu is recognized for his contributions to the fields of digital health and medical devices, holding 15 pending and issued patents. He has authored over 140 peer-reviewed publications in prestigious journals, including Nature, Science, and The New England Journal of Medicine. In 2022, he was honored as an MIT 35 Under 35 Awardee. His work has significantly impacted the monitoring of respiratory endpoints with continuous wearable sensors, enhancing patient care and clinical research.
Research and Innovation
Steve Xu has directed medical research at the Querrey Simpson Institute for Bioelectronics at Northwestern University. His research focuses on innovations in health monitoring, particularly in the areas of neonatal care and pregnancy. He speaks on the application of continuous wearable sensors for respiratory endpoints, contributing to advancements in patient monitoring technologies.